496 related articles for article (PubMed ID: 1709852)
1. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
Dechant KL; Clissold SP
Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
3. Tianeptine: a review of its use in depressive disorders.
Wagstaff AJ; Ormrod D; Spencer CM
CNS Drugs; 2001; 15(3):231-59. PubMed ID: 11463130
[TBL] [Abstract][Full Text] [Related]
4. Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
Milne RJ; Goa KL
Drugs; 1991 Mar; 41(3):450-77. PubMed ID: 1711447
[TBL] [Abstract][Full Text] [Related]
5. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
Benfield P; Ward A
Drugs; 1986 Oct; 32(4):313-34. PubMed ID: 3096686
[TBL] [Abstract][Full Text] [Related]
6. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
Benfield P; Heel RC; Lewis SP
Drugs; 1986 Dec; 32(6):481-508. PubMed ID: 2878798
[TBL] [Abstract][Full Text] [Related]
8. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.
Harris MG; Benfield P
Drugs Aging; 1995 Jan; 6(1):64-84. PubMed ID: 7696780
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
J Affect Disord; 1990 Apr; 18(4):289-99. PubMed ID: 2140382
[TBL] [Abstract][Full Text] [Related]
10. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
Kuhs H; Schlake HP; Rolf LH; Rudolf GA
Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
[TBL] [Abstract][Full Text] [Related]
11. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
Cohn JB; Wilcox CS
J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner JP; Boyer WF
Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
[TBL] [Abstract][Full Text] [Related]
13. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
Tulloch IF; Johnson AM
J Clin Psychiatry; 1992 Feb; 53 Suppl():7-12. PubMed ID: 1531829
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of paroxetine, a newly developed antidepressant, in anesthetized dogs in comparison with those of imipramine, amitriptyline and clomipramine.
Yokota S; Ishikura Y; Ono H
Jpn J Pharmacol; 1987 Nov; 45(3):335-42. PubMed ID: 2963926
[TBL] [Abstract][Full Text] [Related]
15. Clinical overview of serotonin reuptake inhibitors.
Rickels K; Schweizer E
J Clin Psychiatry; 1990 Dec; 51 Suppl B():9-12. PubMed ID: 2147922
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
Gunasekara NS; Noble S; Benfield P
Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
[TBL] [Abstract][Full Text] [Related]
17. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
[TBL] [Abstract][Full Text] [Related]
18. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner JP; Boyer WF
J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
[TBL] [Abstract][Full Text] [Related]
19. Paroxetine: pharmacokinetic and antidepressant effect in the elderly.
Lundmark J; Scheel Thomsen I; Fjord-Larsen T; Manniche PM; Mengel H; Møller-Nielsen EM; Pauser H; Wålinder J
Acta Psychiatr Scand Suppl; 1989; 350():76-80. PubMed ID: 2530794
[TBL] [Abstract][Full Text] [Related]
20. Paroxetine. A pharmacoeconomic evaluation of its use in depression.
Wilde MI; Whittington R
Pharmacoeconomics; 1995 Jul; 8(1):62-81. PubMed ID: 10155603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
